Neutrophil extracellular traps (NETs) were initially described as an antimicrobial mechanism of neutrophils. Over the last decade, several lines of evidence support the involvement of NETs in a plethora of pathological conditions. Clinical and experimental data indicate that NET release constitutes a shared mechanism, which is involved in a different degree in various manifestations of non-infectious diseases. Even though the backbone of NETs is similar, there are differences in their protein load in different diseases, which represent alterations in neutrophil protein expression in distinct disorder-specific microenvironments. The characterization of NET protein load in different NET-driven disorders could be of significant diagnostic and/or therapeutic value. Additionally, it will provide further evidence for the role of NETs in disease pathogenesis, and it will enable the characterization of disorders in which neutrophils and NET-dependent inflammation are of critical importance.
CITATION STYLE
Mitsios, A., Arampatzioglou, A., Arelaki, S., Mitroulis, I., & Ritis, K. (2017, January 11). NETopathies? Unraveling the dark side of old diseases through neutrophils. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2016.00678
Mendeley helps you to discover research relevant for your work.